These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21586736)

  • 1. Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions.
    Bettari L; Fiuzat M; Becker R; Felker GM; Metra M; O'Connor CM
    Circ Heart Fail; 2011 May; 4(3):361-8. PubMed ID: 21586736
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy for heart failure in sinus rhythm.
    Subramaniam V; Davis RC; Shantsila E; Lip GY
    Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolism and antithrombotic therapy in congestive heart failure.
    Dunkman WB
    J Cardiovasc Risk; 1995 Apr; 2(2):107-17. PubMed ID: 7606647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives].
    Scardi S; Mazzone C
    Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy for patients with valvular heart disease.
    Vahanian A
    Herz; 2008 Feb; 33(1):44-51. PubMed ID: 18273577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism].
    Prati PL; Piazza V
    Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term antithrombotic therapy for the prevention of thromboembolic complications in patients with chronic heart failure].
    Osmolovskaia IuF; Romanova NV; Zhirov IV; Tereshchenko SN
    Kardiologiia; 2014; 54(6):86-90. PubMed ID: 25178085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombotic therapy in congestive heart failure].
    Adam O; Böhm M
    Herz; 2008 Feb; 33(1):20-4. PubMed ID: 18273574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Antithrombotic management early after mechanical heart valve replacement.
    Hering D; Piper C; Horstkotte D
    J Heart Valve Dis; 2008 May; 17(3):332-4. PubMed ID: 18592931
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic therapy in native heart valve disease.
    Völler H
    J Heart Valve Dis; 2004 May; 13(3):325-8. PubMed ID: 15222275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.
    Francescone S; Halperin JL
    J Am Coll Cardiol; 2008 Feb; 51(8):826-7. PubMed ID: 18294567
    [No Abstract]   [Full Text] [Related]  

  • 13. Venous thromboembolism prevention in patients with heart failure: an often neglected issue.
    Imberti D; Pierfranceschi MG; Falciani M; Prisco D
    Pathophysiol Haemost Thromb; 2008; 36(2):69-74. PubMed ID: 19127085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Prisco D
    Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of thromboembolism in non-valvular atrial fibrillation].
    Coccheri S; Cosmi B
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):927-9. PubMed ID: 12497850
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thromboembolism and blood coagulation in congestive heart failure].
    Serbin VI; Muratov AA
    Pediatriia; 1991; (2):92-7. PubMed ID: 2057304
    [No Abstract]   [Full Text] [Related]  

  • 17. [The assessment of the thromboembolic risk and the role of antithrombotic prophylaxis in nonrheumatic atrial fibrillation].
    Fera MS; Giovannini E
    G Ital Cardiol; 1999 Feb; 29(2):193-213. PubMed ID: 10088078
    [No Abstract]   [Full Text] [Related]  

  • 18. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications and possibilities of thrombosis prevention and antithrombotic therapy in cardiology].
    Doĭchinov A; Grozdinski L
    Vutr Boles; 1988; 27(3):22-9. PubMed ID: 3061176
    [No Abstract]   [Full Text] [Related]  

  • 20. Thromboprophylaxis in day surgery.
    Squizzato A; Venco A
    Int J Surg; 2008; 6 Suppl 1():S29-30. PubMed ID: 19121985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.